Universal Health Services Inc (UHS)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 6.29 | 6.19 | 6.47 | 6.60 | 6.58 | 6.90 | 7.07 | 7.32 | 7.19 | 7.02 | 6.79 | 6.99 | 6.64 | 7.32 | 7.77 | 7.59 | 7.21 | 7.20 | 6.83 | 6.72 | |
DSO | days | 58.04 | 58.98 | 56.37 | 55.28 | 55.49 | 52.88 | 51.66 | 49.86 | 50.74 | 51.98 | 53.74 | 52.19 | 55.01 | 49.85 | 46.99 | 48.10 | 50.62 | 50.71 | 53.42 | 54.30 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.29
= 58.04
The days of sales outstanding (DSO) ratio for Universal Health Services, Inc. has shown a slight increase over the last two quarters of 2023 compared to the previous quarters in 2022. In Q4 2023, the DSO stood at 57.20 days, up from 54.96 days in Q4 2022. This indicates that, on average, it took the company 57.20 days to collect its accounts receivable from customers in Q4 2023.
The upward trend in DSO may suggest that Universal Health Services, Inc. is facing challenges in efficiently collecting payments from its customers, potentially impacting its cash flow and liquidity position. It would be important for management to closely monitor and address any issues causing delays in receivables collection to ensure optimal working capital management.
Further analysis and comparison with industry benchmarks could provide additional insights into Universal Health Services, Inc.'s performance in this area and help identify opportunities for improvement in managing receivables effectively.
Peer comparison
Dec 31, 2023